Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo

被引:46
|
作者
Lohner, Katrin
Schnaebele, Kerstin
Daniel, Hannelore
Oesterle, Doris
Rechkemmer, Gerhard
Goettlicher, Martin
Wenzel, Uwe
机构
[1] Univ Giessen, Interdisciplinary Res Ctr, D-35392 Giessen, Germany
[2] Tech Univ Munich, Dept Food & Nutr, Mol Nutr Unit, Freising Weihenstephan, Germany
[3] GSF, Inst Toxicol, Neuherberg, Germany
关键词
C57BL; Caco-2 human intestinal epithelial cells; flavonoids; flow cytometry; P-glycoprotein expression;
D O I
10.1002/mnfr.200600225
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Flavonoids are secondary plant metabolites included in our diet but are also provided in a growing number of supplements. They are suggested to interact with intestinal transport systems including phospbo-glycoprotein (P-gp) which mediates the efflux of a variety of xenobiotics back into the gut lumen. In human intestinal Caco-2 cells, we tested the effects of 14 different flavonoids on P-gp expression in vitro. Protein expression levels were quantified by Western blotting, flow cytometry, and real-time PCR. Except apigenin, all flavonoids at concentrations of 10 mu M increased P-gp expression in Western blotting experiments when cells were exposed to the compounds over 4 wk. Flavone was one of the most effective P-gp inducers in Caco-2 cells and its effects were, therefore, also assessed for changes in P-gp in vivo in the gastrointestinal tract of C57BL/6 mice. P-gp expression was significantly increased by flavone (400 mg/kg body weight x day over 4 wk) in the small intestine but not in the colon which displayed intrinsically the highest expression level. In conclusion, the increase in P-gp expression caused by flavonoids in intestinal epithelial cells in vitro and also in vivo may serve as an adaptation and defense mechanism limiting the entry of lipophilic xenobiotics into the organism.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 50 条
  • [1] In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression
    Han, Yi
    Tan, Theresa May Chin
    Lim, Lee-Yong
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2008, 230 (03) : 283 - 289
  • [2] Acetaminophen (AP) inhibits intestinal P-glycoprotein (P-gp) activity in vitro and in vivo
    Novak, Analia
    Delli Carpini, Griselda
    Laura Ruiz, Maria
    Luquita, Marcelo
    Carlos Rubio, Modesto
    Domingo Mottino, Aldo
    Ines Ghanem, Carolina
    FASEB JOURNAL, 2013, 27
  • [3] In vitro and in vivo evaluation of the effects of duloxetine on P-gp function
    Zhao Ruike
    Cao Junhua
    Peng Wenxing
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (7-8) : 553 - 559
  • [4] P-gp expression in epilepsy
    Vogelgesang, Silke
    EPILEPSIA, 2009, 50 (01) : 156 - 156
  • [5] Expression of P-gp transporter in human nasal epithelial cell monolayers
    Lin, Hongxia
    Cho, Hyun-Jong
    Chung, Suk-Jae
    Shim, Chang-Koo
    Kim, Dae-Duk
    DRUG METABOLISM REVIEWS, 2006, 38 : 70 - 71
  • [6] Flavonoids as P-gp Inhibitors: A Systematic Review of SARs
    Cui, Jiahua
    Liu, Xiaoyang
    Chow, Larry M. C.
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (25) : 4799 - 4831
  • [7] P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats
    Yan Zhang
    Changyuan Wang
    Zhihao Liu
    Qiang Meng
    Xiaokui Huo
    Qi Liu
    Pengyuan Sun
    Xiaobo Yang
    Huijun Sun
    Xiaodong Ma
    Kexin Liu
    Pharmacological Reports, 2018, 70 : 243 - 250
  • [8] P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats
    Zhang, Yan
    Wang, Changyuan
    Liu, Zhihao
    Meng, Qiang
    Huo, Xiaokui
    Liu, Qi
    Sun, Pengyuan
    Yang, Xiaobo
    Sun, Huijun
    Ma, Xiaodong
    Liu, Kexin
    PHARMACOLOGICAL REPORTS, 2018, 70 (02) : 243 - 250
  • [9] Stimulation of P-gp mediated transport & expression by flutamide in vitro.
    Bertelsen, KM
    von Moltke, LL
    Greenblatt, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P42 - P42
  • [10] IN VITRO P-GP EXPRESSION AFTER ADMINISTRATION OF CNS ACTIVE DRUGS
    Nicolae, Alina Crenguta
    Arsene, Andreea Letitia
    Vuta, Vlad
    Popa, Daniela Elena
    Sirbu, Carmen Adella
    Dragomiroiu, George Traian Alexandru Burcea
    Dumitrescu, Ion-Bogdan
    Velescu, Bruno Stefan
    Gofita, Eliza
    Dragoi, Cristina Manuela
    FARMACIA, 2016, 64 (06) : 844 - 850